3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
6
Neuroendocrine Tumors
2
Urogenital Neoplasms
1
Prostatic Diseases
1
Oligometastatic Prostate Cancer (OMPC)
1
Metastatic Neuroendocrine Prostate Cancer
1
Metastatic Castration Resistant Prostate Cancer (mCRPC)
1
Carcinoma, Merkel Cell
1
Carcinoma
1
Advanced Gastroenteropancreatic Neuroendocrine Tumor
1
Interventions
Rituximab
27
acalabrutinib
15
ibrutinib
13
Cyclophosphamide
12
Lenalidomide
10
CT-P10
10
zanubrutinib
9
venetoclax
9
Magnetic Resonance Spectroscopy
8
obinutuzumab
7
Specimen Handling
7
Cytarabine
7
Bendamustine Hydrochloride
7
pirtobrutinib
6
fludarabine
6
Biopsy
6
glofitamab
5
fludarabine phosphate
5
Peripheral Blood Stem Cell Transplantation
5
Cyclosporine
5
brexucabtagene autoleucel
4
Whole-Body Irradiation
4
Mycophenolic Acid
4
Vincristine
3
Stem Cell Transplantation
3
Sirolimus
3
Methotrexate
3
Etoposide
3
Doxorubicin
3
Cyclosporins
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Mantle-Cell
×
Lutetium-177
×
90 days
×
Clear all
No trials found.